Clara Montagut

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Association of ctDNA RAS mutational status and clinical benefits in first-line metastatic colorectal cancer therapy with chemotherapy plus anti-EGFR (overall response rate and progression-free survival): a brief report of systematic review and meta-analysis.

Association of ctDNA RAS mutational status and clinical benefits in first-line metastatic colorectal cancer therapy with chemotherapy plus anti-EGFR (overall response rate and progression-free survival): a brief report of systematic review and meta-analysis.

Journal: Journal of gastrointestinal oncology

Published: February 09, 2026

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 21, 2026

Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.

Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 15, 2026

Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Journal: Gut

Published: August 25, 2025

ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors.

ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors.

Journal: British journal of cancer

Published: April 07, 2025

Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study.

Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study.

Journal: ESMO open

Published: March 22, 2025

Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives.

Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives.

Journal: Cancers

Published: March 22, 2025

A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer.

A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer.

Journal: ESMO open

Published: March 12, 2025

FOxTROT: is anti-EGFR a good dancing partner?

FOxTROT: is anti-EGFR a good dancing partner?

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 19, 2025

SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023).

SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 03, 2024

Analysis of Shared Variants between Cancer Biospecimens.

Analysis of Shared Variants between Cancer Biospecimens.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 23, 2024

The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

Journal: Cancer discovery

Published: April 18, 2024

Showing 1-12 of 83

Last Updated: 09/26/2026